Imaging in 2020
September 26-30, 1999
Organizers: Thomas Meade, Daniel Sullivan, and James Tatum
SUNDAY
The Future of Medical Imaging
Dan Sullivan, National Cancer Institute
The Challenges and Promise of In Vivo Imaging at Cellular and Subcellular Resolutions
Scott Fraser, C/spanalifornia Institute of Technology
TUESDAY
Chair: Bill Strauss, Stanford University
Molecular and Cellular Imaging of the Cardiovascular System
Sam Wickline, Washington University
Assessing the Efficacy of Anti-Tumor Therapy using Radiolabeled Annexin V: Is there Life after Death?
Francis Blankenberg, Lucile Salter Packard Children’s Hospital
Brain Function and Neurochemistry by Magnetic Resonance?
Kamil Ugurbil, University of Minnesota
New Reagents for the Targeted Delivery of Metal Ions
Claude Meares, UC Davis
Keynote Address
Mapping the Human Brain in 2020 – What Did We Learn 21 Years Ago?
John Mazziota, UCLA
THURSDAY
Chair: Tom Meade,California Institute of Technology
Applications of PET in Assessment of Tumor Therapy
Michael Welch, Washington University
Smart MRI Contrast Without the Smart Chemistry
Alan Koretsky, Carnegie Mellon Research Institute
What Can We Learn from Noninvasive Measurements of the Tumoral Pharmacokinetics of Drugs? Scientific and Clinical Utility
Walter Wolf, University of Southern California
Seeing is Believing: Monitoring In Vivo Gene Expression by Magnetic Resonance Imaging
Tom Meade, California Institute of Technology
MONDAY
Cancer Imaging: Meeting the Challenges
Janet Husband, Royal Marsden Hospital
Biological Imaging: From Metabolism to Gene ExpressionMichael Phelps, UCLA
Advanced 3-D Microscopes and Multiscale Views of Nervous SystemMark Ellisman, UC San Diego
Diagnostic and Therapeutic Applications of MicrobubblesEvan Unger, University of Arizona
The Use of Dendrimers in Biomedical Targeting and Imaging ApplicationsDonald Tomalia, Michigan Molecular Institute
Imaging Signal Transduction with Genetically Encoded IndicatorsRoger Tsien, UC San Diego
When Imaging is Not Enough? Neurochemistry in Real Time.Brian Ross, Huntington Medical Research Institutes
WEDNESDAY
Chair: Tom Budinger, Lawrence Berkeley National Lab
Ultrasound in 2020
Kathy Ferrara, UC Davis
Imaging the Tumor Biology of Progression and Response in Prostate Cancer
Steven Larson, Memorial Sloan-Kettering Cancer Center
Three-Dimensional Magnetic Resonance Microscopy
G. Allen Johnson, Duke University
High-Resolution Optical Bioimaging: 20/20 by 2020?
Daniel Farkas, University of Pittsburgh
Can MRI Agents Compete in the Biochemical Imaging Arena?
Mike Tweedle, Bracco Research
Imaging Gene Delivery Expression In Vivo
Ralph Weissleder, Massachusetts General Hospital
Molecular Imaging: Advantages and Limitations
Ron Blasberg, Memorial Sloan-Kettering Cancer Center